123 related articles for article (PubMed ID: 1868647)
1. Comparison of scintigraphic renal differentials using radiolabeled orthoiodohippurate and glucoheptonate.
Jacobson AF; Matsuoka DT; Ferency GF; Miura RS; Avrin SA
Clin Nucl Med; 1991 Jun; 16(6):389-93. PubMed ID: 1868647
[TBL] [Abstract][Full Text] [Related]
2. [Renography and renal imaging with 123I-orthoiodohippurate; comparison with 131I-orthoiodohippurate].
Kubo A; Hashimoto J; Fujii H; Tokumaru M; Sanmiya T; Yamashita H; Hashimoto S
Rinsho Hoshasen; 1989 Nov; 34(12):1437-41. PubMed ID: 2593287
[TBL] [Abstract][Full Text] [Related]
3. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical.
Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN
Clin Nucl Med; 1994 Apr; 19(4):314-20. PubMed ID: 8004863
[TBL] [Abstract][Full Text] [Related]
5. Clinical evaluation of Tc-99m cystine. A new renal radiopharmaceutical.
Misra M; Das BK; Gambhir S; Mittal BR; Sewatkar AB; Ghosh S; Banerjee SN
Clin Nucl Med; 1994 May; 19(5):446-51. PubMed ID: 8039322
[TBL] [Abstract][Full Text] [Related]
6. The effect of captopril on glucoheptonate uptake in experimental renal artery stenosis.
Gale B; Zhang C; Lee HB; Heller S; Blaufox MD
Nucl Med Commun; 1992 Feb; 13(2):110-3. PubMed ID: 1436896
[TBL] [Abstract][Full Text] [Related]
7. A physiologic approach to renal scintigraphy. Application to evaluation of hypertension.
Turpin S; Lambert R; Milot A; Taillefer R; Leveille J; Lefebvre B
Clin Nucl Med; 1995 Mar; 20(3):206-10. PubMed ID: 7750211
[TBL] [Abstract][Full Text] [Related]
8. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
9. 99Tcm-cystine, a renal function and imaging agent: a comparative study in dog with 131I-hippurate and 99Tcm-glucoheptonate to evaluate its functional and imaging characteristics.
Misra M; Sarkar HS; Chakravarty M; Sanyal S; Ganguly S; Sarkar BR; Chatterjee J; Dobe P; Ghosh S; Banerjee S
Nucl Med Commun; 1994 Nov; 15(11):878-85. PubMed ID: 7870394
[TBL] [Abstract][Full Text] [Related]
10. [Clinical evaluation of renoscintigraphy using 123I-orthoiodohippurate--comparison with 131I-OIH and measurement of the effective renal blood flow].
Ishii K; Tadokoro K; Nishimaki H; Nakazawa K; Matsubayashi T; Ishibashi A; Ishida H
Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Jan; 50(1):68-75. PubMed ID: 2330288
[TBL] [Abstract][Full Text] [Related]
11. [Measurement of effective renal plasma flow (ERPF) with 123I-orthoiodohippurate (OIH)].
Takayama T; Tada A; Aburano T; Tonami N; Hisada K; Yamada M
Kaku Igaku; 1983 Jul; 20(6):841-7. PubMed ID: 6663899
[No Abstract] [Full Text] [Related]
12. Technetium-99m-N,N-ethylenedicysteine--a comparative study of renal scintigraphy with technetium-99m-MAG3 and iodine-131-OIH in patients with obstructive renal disease.
Ozker K; Onsel C; Kabasakal L; Sayman HB; Uslu I; Bozluolçay S; Cansiz T; Kapicioğlu T; Urgancioğlu I
J Nucl Med; 1994 May; 35(5):840-5. PubMed ID: 8176468
[TBL] [Abstract][Full Text] [Related]
13. Phase II study of Tc-99m MAG3 in patients with nephrourologic diseases.
Itoh K; Tsukamoto E; Kakizaki H; Nonomura K; Koyanagi T; Furudate M; Torizuka K
Clin Nucl Med; 1993 May; 18(5):387-93. PubMed ID: 8508572
[TBL] [Abstract][Full Text] [Related]
14. [A phase III multi-center clinical trial on 123I-orthoiodohippurate (123I-OIH)].
Fukuchi M; Ishimura J; Komatani A; Kera M; Sasaki Y; Oriuchi N; Kubo A; Hashimoto J; Mizuiri S; Fushimi T
Hinyokika Kiyo; 1990 Mar; 36(3):371-82. PubMed ID: 2191576
[TBL] [Abstract][Full Text] [Related]
15. 99mTc-MAG3 versus 131I-orthoiodohippurate in the routine determination of effective renal plasma flow.
Bagni B; Portaluppi F; Montanari L; Prandini N; Zatta G
J Nucl Med Allied Sci; 1990; 34(2):67-70. PubMed ID: 2147211
[TBL] [Abstract][Full Text] [Related]
16. Tc-99m glucoheptonate estimation of glomerular filtration rate. Correlation with endogenous creatinine clearance.
Long SE; Thompson WL; Sonnemaker RE; Pounds BK; Burdine JA
Clin Nucl Med; 1984 May; 9(5):271-4. PubMed ID: 6744766
[TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of renograms with simultaneous injection of 99mTc-DTPA and 131I-OIH--estimation of GFR, ERPF and retention function of individual kidney].
Maeda M; Hasegawa R; Tanaka S; Yoshida H
Kaku Igaku; 1985 Sep; 22(9):1341-52. PubMed ID: 3910897
[No Abstract] [Full Text] [Related]
20. Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio.
Kabasakal L; Atay S; Vural VA; Ozker K; Sönmezoglu K; Demir M; Uslu I; Işitman AT; Onsel C
J Nucl Med; 1995 Aug; 36(8):1398-403. PubMed ID: 7629584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
